Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy

Author： Durna EM   Heller GZ   Leader LR   Sjoblom P   Eden JA   Wren BG  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.7, Iss.3, 2004-09, pp. : 284-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormone replacement therapy and breast cancer morbidity, mortality and recurrence

By Kenemans P.   Scheele F.   Burger C.W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 71, Iss. 2, 1997-02 ,pp. : 199-203

Elsevier

Access to resources Recommend Favorite

Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study

By Dew J. E.   Wren B. G.   Eden J. A.  

Climacteric, Vol. 5, Iss. 2, 2002-06 ,pp. : 151-155

Informa Healthcare

Access to resources Recommend Favorite

The truth about hormone replacement therapy and breast cancer

By Priyadarshi Sewanti   Fernandez Imelyn M   Voige Hayley   Del Priore Giuseppe  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 1, 2007-01 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

Colorectal cancer in women: hormone replacement therapy and chemoprevention

By Barnes E. L.   Long M. D.  

Climacteric, Vol. 15, Iss. 3, 2012-06 ,pp. : 250-255

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women

By Cerne J. Z.   Ferk P.   Leskosek B.   Gersak K.  

Climacteric, Vol. 14, Iss. 4, 2011-08 ,pp. : 458-463

Informa Healthcare

Access to resources Recommend Favorite